← All stocks

FibroBiologics, Inc.

FBLG Net buying
CIK 0001958777 #5291 in the set updated 21 Sep 2026
Bought (12 mo)
$120.56K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$120.56K
+$120.56K against sales at will

By person

4 insiders · 7 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GARCIA RUBEN A
General Counsel
$60.66K (2)
+$60.66K
180,000
$68.11K
Davis Jason
Chief Financial Officer
$28.97K (1)
+$28.97K
70,000
$26.49K
O'HEERON PETE
CHIEF EXECUTIVE OFFICER
$19.53K (3)
+$19.53K
5,958,147
$2.25M
−1.6%
Khoja Hamid
Chief Scientific Officer
$11.40K (1)
+$11.40K
301,571
$114.11K

No percentages here. This company's share count has moved by a factor of 9.9 over the window, from 5,208,915 to 51,456,077 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
O'HEERON PETE
4 Mar 2026
CHIEF EXECUTIVE OFFICER
Buy
15,872
$0.38
$6.01K
Khoja Hamid
4 Mar 2026
Chief Scientific Officer
Buy
30,000
$0.38
$11.40K
O'HEERON PETE
3 Mar 2026
CHIEF EXECUTIVE OFFICER
Buy
18,200
$0.41
$7.37K
Davis Jason
2 Mar 2026
Chief Financial Officer
Buy
70,000
$0.41
$28.97K
O'HEERON PETE
2 Mar 2026
CHIEF EXECUTIVE OFFICER
Buy
17,428
$0.35
$6.15K
GARCIA RUBEN A
27 Feb 2026
General Counsel
Buy
40,000
$0.33
$13.06K
GARCIA RUBEN A
11 Dec 2025
General Counsel
Buy
140,000
$0.34
$47.60K

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 298,508
History held since 8 Mar 2024